+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Syncytial Virus Vaccine for Children Market - Global Forecast 2025-2030- Product Image
Respiratory Syncytial Virus Vaccine for Children Market - Global Forecast 2025-2030- Product Image
Sale

Respiratory Syncytial Virus Vaccine for Children Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081999
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pediatric RSV vaccine market is at a pivotal stage, driven by the urgent need to protect infants and young children from respiratory syncytial virus. Senior decision-makers face complex choices amid evolving vaccine technologies, fluctuating regulations, and shifting global market conditions.

Pediatric RSV Vaccine Market Snapshot

Demand for pediatric RSV vaccines is surging as healthcare systems and regulatory agencies prioritize infant health. The market is characterized by rapid technological advancements, adaptive regulatory frameworks, and robust public-private collaborations. This landscape is transforming with the integration of messenger RNA vaccines, protein subunit options, monoclonal antibodies, and a growing emphasis on maternal immunization strategies. Regulatory innovations now streamline approval while expanding access through targeted infrastructure and policy initiatives.

Scope & Segmentation

This comprehensive study delivers in-depth analysis and forecasts across key segments and regions, arming industry leaders with actionable intelligence.

  • Vaccine Types: Live attenuated vaccines, monoclonal antibodies, messenger RNA vaccines, subunit vaccines—including protein subunit and virus-like particle formats—and vector-based vaccines.
  • Distribution Channels: Clinic pharmacies, hospital pharmacies, online pharmacies, and retail pharmacies.
  • Age Groups: 0 to 6 months (full-term and preterm infants), 6 to 12 months, and 12 to 24 months.
  • Dose Regimens: Single-dose and multi-dose formulations, including two- and three-dose series.
  • End Users: Ambulatory care centers, clinics, hospitals (both private and public).
  • Regional Coverage: Comprehensive insights spanning Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and other key markets), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: AstraZeneca plc, Sanofi S.A., Pfizer Inc., GlaxoSmithKline plc, Moderna, Inc., Bavarian Nordic A/S, Janssen Pharmaceuticals, Inc., Meissa Vaccines, Inc., BioNTech SE, CureVac N.V.

Key Takeaways

  • Innovation in immunology and vaccine platform design is driving a shift from traditional approaches to advanced solutions such as mRNA constructs and protein subunit assemblies.
  • Regulatory agencies are expediting pathways by leveraging real-world evidence and adaptive clinical trial models without compromising safety standards.
  • Collaborative efforts—from supply chain diversification to enhanced cold chain integrity—are responding to complex logistics, especially for sensitive age cohorts and multi-dose regimens.
  • Tariff fluctuations in the United States have increased supply chain and production costs, prompting manufacturers to explore near-sourcing and regional production strategies.
  • Distinct regional dynamics influence adoption speed and implementation, with the Americas leveraging established infrastructures and Asia-Pacific markets navigating greater regulatory variability and local manufacturing partnerships.
  • Competitor strategies focus on pipeline diversity, scalable manufacturing, and alliances, signaling the importance of operational flexibility and stakeholder engagement in long-term market positioning.

Tariff Impact on Pediatric RSV Vaccine Supply Chains

US tariff adjustments effective 2025 are reshaping procurement strategies spanning raw materials, cold chain equipment, and distribution assets. Elevated import duties have catalyzed near-sourcing, domestic supplier partnerships, and supply chain optimization to minimize disruption. These adjustments prompt the sector to reevaluate logistics models, reduce buffer stock, and seek policy dialogue for targeted tariff exemptions. While cost pressures are immediate, these disruptions reinforce resilience and foster transparency, ultimately supporting improved vaccine access and affordability.

Methodology & Data Sources

This market analysis uses a mixed-methods approach, combining desk research from scientific publications, regulatory databases, clinical trial registries, and policy documents with in-depth interviews with immunologists, regulatory experts, supply chain professionals, pharmacists, and pediatric care practitioners. Data were triangulated to ensure context and validated through multi-layer reviews, including peer assessment by external subject-matter experts to confirm methodological rigor.

Why This Report Matters

  • Enables strategic planning by presenting actionable segmentation and adoption insights across vaccine technologies, distribution models, and care settings.
  • Equips decision-makers to adapt to regulatory, tariff, and regional shifts while expanding partnerships and supply resilience.
  • Provides a clear roadmap for competitive differentiation, policy alignment, and stakeholder engagement in advancing RSV prevention for infants globally.

Conclusion

Decision-makers navigating the pediatric RSV vaccine market gain critical clarity from this executive summary. With the convergence of innovation, policy, and global collaboration, stakeholders are positioned to drive meaningful improvements in infant respiratory health. The insights outlined here support informed strategy, adaptive execution, and long-term value creation in this evolving healthcare segment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of next-generation mRNA technology in pediatric RSV vaccine development pipelines
5.2. Impact of recent FDA approval pathways on accelerated pediatric RSV vaccine commercialization timelines
5.3. Analysis of dosage optimization studies to minimize adverse events in infant RSV immunization programs
5.4. Role of global supply chain enhancements in improving access to RSV vaccines for low-income regions
5.5. Adoption of combined pediatric immunization schedules to include RSV vaccines alongside routine infant shots
5.6. Emerging competitive landscape analysis of pediatric RSV vaccines in Phase III trials across markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Respiratory Syncytial Virus Vaccine for Children Market, by Vaccine Type
8.1. Introduction
8.2. Live Attenuated Vaccine
8.3. Monoclonal Antibody
8.4. mRNA Vaccine
8.5. Subunit Vaccine
8.5.1. Protein Subunit
8.5.2. Virus Like Particle
8.6. Vector Based Vaccine
9. Respiratory Syncytial Virus Vaccine for Children Market, by Distribution Channel
9.1. Introduction
9.2. Clinic Pharmacies
9.3. Hospital Pharmacies
9.4. Online Pharmacies
9.5. Retail Pharmacies
10. Respiratory Syncytial Virus Vaccine for Children Market, by Age Group
10.1. Introduction
10.2. 0 To 6 Months
10.2.1. Full Term Infants
10.2.2. Preterm Infants
10.3. 12 To 24 Months
10.4. 6 To 12 Months
11. Respiratory Syncytial Virus Vaccine for Children Market, by Dose Regimen
11.1. Introduction
11.2. Multi Dose
11.2.1. Three Dose Series
11.2.2. Two Dose Series
11.3. Single Dose
12. Respiratory Syncytial Virus Vaccine for Children Market, by End User
12.1. Introduction
12.2. Ambulatory Care Centers
12.3. Clinics
12.4. Hospitals
12.4.1. Private Hospitals
12.4.2. Public Hospitals
13. Americas Respiratory Syncytial Virus Vaccine for Children Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Respiratory Syncytial Virus Vaccine for Children Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Respiratory Syncytial Virus Vaccine for Children Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AstraZeneca plc
16.3.2. Sanofi S.A.
16.3.3. Pfizer Inc.
16.3.4. GlaxoSmithKline plc
16.3.5. Moderna, Inc.
16.3.6. Bavarian Nordic A/S
16.3.7. Janssen Pharmaceuticals, Inc.
16.3.8. Meissa Vaccines, Inc.
16.3.9. BioNTech SE
16.3.10. CureVac N.V.
17. ResearchAI18. ResearchStatistics19. ResearchContacts20. ResearchArticles21. Appendix
List of Figures
FIGURE 1. RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET: RESEARCHAI
FIGURE 26. RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET: RESEARCHSTATISTICS
FIGURE 27. RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET: RESEARCHCONTACTS
FIGURE 28. RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MRNA VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MRNA VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY PROTEIN SUBUNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY PROTEIN SUBUNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VIRUS LIKE PARTICLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VIRUS LIKE PARTICLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VECTOR BASED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VECTOR BASED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY CLINIC PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY CLINIC PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY FULL TERM INFANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY FULL TERM INFANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY PRETERM INFANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY PRETERM INFANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 12 TO 24 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 12 TO 24 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 6 TO 12 MONTHS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 6 TO 12 MONTHS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY THREE DOSE SERIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY THREE DOSE SERIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY TWO DOSE SERIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY TWO DOSE SERIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 120. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 121. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 126. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 127. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 128. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 129. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 130. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 131. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 134. CANADA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 142. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 143. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 144. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 145. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 146. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 147. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 227. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 230. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 231. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 234. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 235. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 236. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 237. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 238. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 239. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 244. GERMANY RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 245. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2018-2024 (USD MILLION)
TABLE 248. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY SUBUNIT VACCINE, 2025-2030 (USD MILLION)
TABLE 249. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 252. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 253. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2018-2024 (USD MILLION)
TABLE 254. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY 0 TO 6 MONTHS, 2025-2030 (USD MILLION)
TABLE 255. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2018-2024 (USD MILLION)
TABLE 256. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY DOSE REGIMEN, 2025-2030 (USD MILLION)
TABLE 257. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY MULTI DOSE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. FRANCE RESPIRATORY SYNCYTIAL VIRUS VACCINE FOR CHILDREN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. FRANCE RES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Respiratory Syncytial Virus Vaccine for Children market report include:
  • AstraZeneca plc
  • Sanofi S.A.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Moderna, Inc.
  • Bavarian Nordic A/S
  • Janssen Pharmaceuticals, Inc.
  • Meissa Vaccines, Inc.
  • BioNTech SE
  • CureVac N.V.

Related Topics

Related Reports

Respiratory Syncytial Virus Vaccines Market Size, Share & Trends Analysis Report By Type (Passive Immunization, Preventive Vaccines), By Technology, By Targeted Population, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Respiratory Syncytial Virus Vaccines Market Size, Share & Trends Analysis Report By Type (Passive Immunization, Preventive Vaccines), By Technology, By Targeted Population, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Respiratory Syncytial Virus Vaccine for the Elderly Market - Global Forecast 2025-2030 - Product Image

Respiratory Syncytial Virus Vaccine for the Elderly Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Respiratory Syncytial Virus Vaccine Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Respiratory Syncytial Virus Vaccine Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Respiratory Syncytial Virus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Respiratory Syncytial Virus Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Respiratory Syncytial Virus Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Respiratory Syncytial Virus Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 82 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.